IFNA2 and Miyoshi myopathy: Such widespread toxicity coupled with the typically high doses of IFNα required for efficacy in MM patients translates into a narrow therapeutic index (TI) for IFNα, defined as the ratio between maximum tolerated dose and minimum therapeutic dose.